More research is needed to establish the benefit-risk profile of curcumin.
Burgos-Morón
Estefanía
E
Calderón-Montaño
José Manuel
JM
Pérez-Guerrero
Concepción
C
López-Lázaro
Miguel
M
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D003474:Curcumin / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use; D004247:DNA / Q000378:metabolism*; D004587:Electrophoresis, Agar Gel; D006801:Humans; D007364:Intercalating Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology
D000970:Antineoplastic Agents; D007364:Intercalating Agents; D004247:DNA; D003474:Curcumin